Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

U. of Maryland prepared to begin clinical testing of Multikine for cervical cancer

May 9, 2001

Major global cancer vaccine collaboration announced by Merck and Biomira

May 7, 2001

Antisoma's Therex stimulates immune system to fight breast cancer

May 3, 2001

Synthetic globo H conjugate tested in breast cancer patients

May 2, 2001

ImClone Systems achieves milestone in BEC2 collaboration with Merck KGaA

April 30, 2001

New HspE7 data confirm earlier findings in anal dysplasia

April 26, 2001

Immune response boosted by MVA-BN melanoma vaccine

April 23, 2001

Cell Genesys commences phase I/II trial of high-potency GVAX

April 19, 2001

Titan's CeaVac and TriAb studied in combination with radiation therapy for NSCLC

April 17, 2001

Herceptin receives Japanese approval for treatment of metastatic breast cancer

April 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...